The tumor suppressor Smad4 is involved in carcinogenesis mainly of the pancreas and colon. Functional inactivation of Smad4 is a genetically late event that occurs upon transition from premalignant stages to invasive and metastatic growth. Smad4 encodes an intracellular messenger common to all signalling cascades induced by members of the transforming growth factor-b (TGF-b) superfamily of cytokines. Despite extensive knowledge about the mechanisms of TGF-b/Smad signal transduction, little is known about Smad4 targets involved in the transition to malignancy. The hallmark of invasive growth is a breakdown of the basement membrane (BM), a specialized sheet of extracellular matrix produced through cooperation of epithelial and stromal cells. Laminin-5, a heterotrimeric epithelial-derived BM component, is commonly lost in carcinomas but not in premalignant tumors. Herein, we report that in human colon and pancreatic tumor cells, Smad4 functions as a positive transcriptional regulator of all three genes encoding laminin-5. Coordinate re-expression of the three laminin-5 chains induced by reconstitution of Smad4 leads to secretion and deposition of the heterotrimeric molecule in BM-like structures. These data define the expression control of an essential BM component as a novel function for the tumor suppressor Smad4.
Introduction
Carcinogenesis is a multistep process that reflects an accumulation of genetic and epigenetic events leading to deregulated cellular growth control and to the acquisition of qualitatively new capabilities like invasiveness (Hanahan and Weinberg, 2000) . The tumor suppressor Smad4 is mainly involved in carcinogenesis of the pancreas and colon. Its inactivation is a genetically late event associated with the acquisition of invasiveness. In pancreatic carcinogenesis, loss of Smad4 rarely occurs in premalignant lesions, but in approximately every second invasive tumor (Wilentz et al., 2000; Luettges et al., 2001) . Also, in colorectal cancers, Smad4 alterations have not been detected in premalignant stages, but are found in carcinomas and at increased frequencies in metastatic colorectal cancers (Miyaki et al., 1999; Maitra et al., 2000) . A genetic mouse model also suggested an association of Smad4 loss with the acquisition of invasiveness: whereas APC single knockout mice, a model for human familial adenomatous polyposis, develop numerous benign polyps in the small intestine and colon, tumors in APC/DPC4 compound double knockout mice frequently progressed into malignant lesions invading into the submucosa (Takaku et al., 1998) .
We have chosen Smad4-deficient human pancreatic and colorectal cancer cell lines as models to address Smad4's function as a tumor suppressor. By gene transfer, we have stably reconstituted Smad4 and we have previously reported that re-expression of Smad4 at a physiological level was adequate to suppress tumor growth in nude mice (Schwarte-Waldhoff et al., 1999 . We observed a morphological reversion of Smad4-re-expressing SW480 human colon carcinoma cells from a mesenchymal-like spindle cell shape to an epithelioid morphology. The investigation of marker genes of epithelial differentiation led to the identification of the invasion suppressor E-cadherin as a Smad4 target gene (Muller et al., 2002) .
Invasion is the result of complex interactions of tumor cells with host cells and extracellular matrices (Lukashev and Werb, 1998; Hanahan and Weinberg, 2000; Liotta and Kohn, 2001; Thiery, 2002) . In order to invade, epithelial cancer cells need to penetrate through the basement membrane (BM), a specialized sheet-like structure of the extracellular matrix, that separates epithelium from connective tissue. BMs are built through interaction of epithelial and mesenchymal cells, which both provide components, mainly the laminins and collagen IV, respectively (Simon-Assmann et al., 1998) . The epithelial-derived laminins constitute a family of at least 15 different isoforms in mammals, each an a x b y g z heterotrimer derived from a combination of one, each, out of five a, three b and three g glycoprotein subunits (Patarroyo et al., 2002; GivantHorwitz et al., 2005) . In the gastrointestinal tract, a single-layered epithelial sheet is separated from the underlying mesenchyme through a BM containing laminins 1, 2, 5 and 10, which are expressed in a characteristic regional and development dependent pattern (Simon-Assmann et al., 1998; Teller and Beaulieu, 2001) . Epithelial cells adhere to the laminins via a distinct set of integrins and non-integrin receptors. These interactions regulate multiple cellular functions during development and in the adult, including proliferation, migration, differentiation and cell death; thus, the regulation of laminin expression is essential for tissue homeostasis and function. The malignant transformation of epithelia is accompanied by various changes in the laminin distribution; in colorectal and in pancreatic carcinogenesis, laminin-5 expression is retained in premalignant stages but, corresponding with the breakdown of BMs, laminin-5 deposition is discontinuous or absent in carcinomas (Sordat et al., 1998; Lohi, 2001; Patarroyo et al., 2002; Katayama and Sekiguchi, 2004; Takahashi et al., 2004) . The fragmentation or absence of BM structures seen in malignant tumors may be due either to active proteolytic degradation or to decreased synthesis of BM components (Giannelli and Antonaci, 2000) . Proteolytic degradation of BMs has been intensively investigated. It appears to be predominantly executed by proteases released from stromal cell types like activated fibroblasts and inflammatory cells, which are recruited through signals derived from the incipient tumor cells. Molecular mechanisms underlying decreased synthesis of BM components, on the other hand, have not yet been addressed.
Herein, we report that in human colon and pancreatic tumor cells, the tumor and invasion suppressor Smad4 functions as a positive transcriptional regulator of all three laminin chains, which constitute the heterotrimeric laminin-5. Coordinate re-expression of the three laminin-5 chains induced by reconstitution of Smad4 leads to secretion and deposition of the heterotrimeric molecule in BM-like structures in vitro and in vivo. As laminin-5 is crucial as an anchor for epithelial cells to the BM, and as a regulator of polarization and differentiation, these data suggest that laminin-5 may represent an important target structure of the tumor and invasion suppressor Smad4 relevant for the maintenance of tissue homeostasis.
Results
Increased adhesiveness of matrices produced by Smad4-re-expressing SW480 human colon carcinoma cells is due to increased expression of laminin-5 We have previously established Smad4-re-expressing cell clones in SW480 human colon carcinoma cells through stable transfection. The Smad4 levels attained in this model reached between one-third to one-half of the endogenous levels present in Smad4-positive cells. Reexpression of Smad4 in SW480 human colon carcinoma cells was capable of suppressing tumor growth in nude mice (Schwarte-Waldhoff et al., 1999) . Moreover, Smad4 restoration was associated with transcriptional induction of E-cadherin, with morphological reversion from a mesenchymal-like spindle cell shape to an epithelioid phenotype, and with partial differentiation in vitro and in vivo (Muller et al., 2002) . Investigating the migratory behavior of these cells in vitro, we became aware of the fact that matrix deposited by the Smad4-reexpressing cells on tissue culture plates induced rapid adhesion and spreading of indicator cells (Figure 1a ). In vivo, intestinal epithelial cells are attached to and migrate on the BM. We hypothesized that the matrix produced by cultured cancer cells in vitro may reflect epithelial contributions to the BM in vivo. One major Figure 1 Increased adhesiveness on matrices produced by Smad4-positive SW480 cells is due to laminin-5. (a) Indicator cells were plated on matrices deposited either by Smad4-negative or Smad4-positive SW480 cells. The number of cells attached to the two different matrices in all experiments (>5) consistently differed by a factor of five to 10. As indicator cells, we also used SW480 cells (Smad4-re-expressing and Smad4-deficient derivatives) as well as other colon cancer cell lines (SW620, HT29), all with similar results. The photographs depicted in (a) show a representative experiment using Smad4-deficient SW480 cells as indicators. (b) Matrices derived from Smad4-positive SW480 cells were preincubated with anti-laminin-5 antibody (Ln-5 Ab) or control antibody (control Ab) at the indicated concentrations. The adhesion assay was performed as in (a) and adherent cells were counted.
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M Zapatka et al adhesive component of epithelial BMs is laminin-5. Laminin-5 is composed of a3, b3 and g2 chains, and the latter two occur exclusively in laminin-5. The laminin-5 expression levels in matrix proteins of Smad4-negative and Smad4-re-expressing SW480 cells were assessed by Western blotting under non-reducing conditions with a g2-specific antibody. Protein levels of the heterotrimeric molecule were strongly and consistently increased in matrices produced by three independent Smad4-re-expressing clones (Figure 2a) . Pretreatment of these matrices with a function-blocking anti-laminin-5 antibody strongly suppressed adhesion of indicator cells in a concentration-dependent manner, confirming that increased adhesiveness was conferred through deposition of laminin-5 (Figure 1b) . Laminin-5 levels were similarly increased in conditioned media (Figure 2a ). Western blotting of conditioned media and of cell lysates under reducing conditions with antibodies specific for each of the three chains revealed that expression of all three constituents of laminin-5 was co-ordinately increased in a Smad4-dependent manner ( Figure 2b and data not shown). The Smad4 effect was at the level of transcription as shown by Northern blotting with chain-specific probes ( Figure 2c ).
Smad4-dependent laminin-5 deposition in an in vitro model of BM formation
The coordinate re-expression of the three chains composing laminin-5 prompted us to ask if Smad4-mediated laminin-5 expression in SW480 colon carcinoma cells was adequate to contribute to BM formation, which in vivo is the result of interactions between epithelial cells and fibroblasts. Cocultures of epithelial cells and organ-specific fibroblasts can be used to mimic this process in vitro (Bouziges et al., 1991) . Thus, Smad4-deficient and Smad4-positive SW480 cells were plated on fibroblast layers and cocultured for 11 days.
Immunostaining of cryosections revealed much stronger and more regular staining for laminin-5 at the interface of fibroblasts and epithelial cells in cocultures with Smad4-positive cells, whether the g2-specific antibody or an antiserum-detecting heterotrimeric laminin-5 were used (Figures 3a and b) . Cell adhesion to laminin-5 is mediated through integrin a6b4. Both integrin subunits exhibited stronger staining in more segregated structures in cocultures with Smad4-positive cells (Figure 3c and d). In contrast, no significant difference was detected by immunostaining with an anti-laminin antiserum, which detects all laminin isoforms containing an a1, b1 or g1 chain (including laminin-1, -2 and -10) (Figure 3e ). Likewise, an antibody specific for collagen IV as a typical fibroblast-derived component produced similar pictures in cocultures with Smad4-deficient and Smad4-positive cells (Figure 3f ). These findings confirm that Smad4-positive SW480 cells express increased levels of laminin-5, which is deposited in a BM-like structure. The Smad4-dependent difference in laminin expression is confined to the laminin-5 isoform, as a pan-specific antiserum that detects all other laminin isoforms expressed in the gastrointestinal tract does not show significant differences. Figure 2 Expression of laminin-5 is strongly increased in Smad4-re-expressing SW480 cell clones. (a) Proteins, 4 mg/lane, from either matrices or conditioned media produced by Smad4-negative or Smad4-positive SW480 cells, three independent clones, each, were separated on polyacrylamide gels under non-reducing conditions and blotted. Incubation with an anti-laminin-g2 chain-specific antibody detects high-molecular weight trimeric laminin-5. Conditioned medium derived from HaCaT cells was used as a positive control. (b) The level of all three subunits of laminin-5 is increased in conditioned media (8 mg/lane) derived from Smad4-re-expressing cell clones. Western blots were performed under reducing conditions and incubated with chain-specific antibodies. Western blots with cell lysates also depicted Smad4-dependent differential expression of all three chains, although lower concentrations of the proteins were present in the lysates as compared to the conditioned media (data not shown). (c) Smad4-re-expressing cell clones consistently exhibit increased mRNA levels of the three genes encoding laminin-5 (LAMA3, LAMB3, LAMC2).
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Staining of laminin-g2-containing BM-like structures in experimental nude mouse tumors We have previously reported that re-expression of Smad4 is adequate to suppress tumor growth (Schwarte-Waldhoff et al., 1999 . Smad4-reexpressing SW480 cells form 'transient' tumors in nude mice, only (Muller et al., 2002) . These tumors grow to a size of 1-4 mm in diameter within 10-14 days and completely disappear after 3-4 weeks, whereas their Smad4-negative counterparts show progressive growth. Transient tumors derived from Smad4-positive SW480 cells display a significantly altered growth pattern with a tendency toward tubular differentiation (Muller et al., 2002) . We wondered if this altered differentiation was associated with laminin-5 deposition in vivo in these transient tumors.
It is generally believed that extracellular laminin deposited in BM structures is not amenable to immunohistochemical staining when the tissue is fixed in formalin. However, as previously published by Mizushima et al. (1998) , laminin-5 epitopes can be detected in formalinfixed tissues when sections are pretreated with protease XXIV. Using this protocol, the g2 chain constituent of laminin-5 was detected at the interface of epithelial cells and underlying stroma in normal human colonic crypts ( Figure 4a ). Likewise, tubular structures of Smad4-positive SW480 cells in tumors grafted in nude mice were surrounded by extracellular laminin-g2 chain ( Figure 4b ). Smad4-negative SW480 cells did not form tubular structures and, correspondingly, did not display detectable extracellular laminin-g2 ( Figure 4c ).
Expression of all three laminin-5 chains is induced by TGF-b in human colon adenoma cells and in Smad4-reconstituted human pancreatic adenocarcinoma cells Transcriptional induction of the laminin-5 subunits in response to transforming growth factor-b (TGF-b) has previously been reported in cultured human keratinocytes (Korang et al., 1995; Jonson et al., 2003) . As Smad4 is a central component in signalling cascades of the TGF-b superfamily of cytokines, we wished to investigate Smad4-dependent TGF-b responses with respect to laminin-5 expression. SW480 cells, however, retain TGF-b resistance as measured in terms of growth inhibition and induction of classical target genes also after stable re-expression of Smad4, presumably owing to scarce or absent expression of the TGF-b type II receptor (Schwarte-Waldhoff et al., 1999) . Also, these Smad4-expressing SW480 derivatives do not show TGF-b induction of the laminin genes (data not shown). Therefore, TGF-b responses of the laminin genes were analysed and quantified in human LT97 cells. The LT97 cell line was developed from a human adenoma and reflects genetic alterations typical for early-stage colon carcinogenesis, namely inactivation of APC and oncogenic mutation of Ki-ras (Richter et al., 2002) . All three laminin-5 chains exhibited significant increases in expression levels in response to TGF-b (Figure 5a and b) . At the protein level, strong increases of secreted laminin-5 were observed at 48 h of induction (Figure 5c ). 
Smad4 inactivation is predominantly involved in pancreatic carcinogenesis. Thus, we wished to extend our analyses to pancreatic carcinoma cells. To that aim, Smad4 expression was stably restored by retroviral transduction in Smad4-deficient human pancreatic adenocarcinoma cell lines, namely BxPC3 and CFPAC-1. Smad4 expression levels attained in these models were higher than in SW480 transfectants and reached approximately threefold levels of endogenous levels in Smad4-positive cells (data not shown). Constitutive and TGF-b-induced expression levels of the three laminin-5 genes were assessed in Smad4-deficient and Smad4-re-expressing derivatives. Smad4-dependent increases in either basal or TGF-b-induced expression levels (or both) were detected in both cell lines for all three laminin-5 chains, although at different extents ( Figure 6a ). As in LT97 adenoma cells, the laminin-5 protein levels in culture supernatants reflected the Smad4-dependent induction evident at the mRNA level (Figure 6b ). Immunohistochemical staining of the laminin-g2 (constitutive of the laminin-5 molecule) on paraffin sections by using a specialized protease pre-treatment protocol. The g2 chain was detected at the interface of epithelial cells and underlying stroma in normal human colonic crypts (a). Likewise, tubular structures of Smad4-positive SW480 cells in tumors grafted in nude mice were surrounded by extracellular laminin-g2 chain (b). Smad4-negative SW480 cells did not form tubular structures and, correspondingly, did not display detectable extracellular laminin-g2 (c) (magnification Â 100 (a) and Â 200 (b, c)).
Smad4-dependent induction of laminin-a3 is mediated through binding to a Smad-binding-element site at À1.5 kb in the LAMA3 promoter In silico sequence analyses of the LAMA3, LAMB3 and LAMC2 gene promoters were performed using MathInspector software. Interestingly, the first Smad-binding element (SBE) upstream from the transcription start sites mapped to approximately position À1.5 kb in all three promoters and additional SBE sites were present within the 5 kb promoter regions of LAMB3 and LAMC2 but not of LAMA3 (data not shown). Thus, the LAMA3 promoter was chosen as a first example to address the molecular mechanisms underlying Smad4-dependent induction of laminin-5 expression.
A chromatin immunoprecipitation (ChIP) assay was established to investigate Smad4 binding to the LAMA3 promoter. Binding of Smad4 to the À1.5 kb region in the LAMA3 promoter could repeatedly be shown in TGF-b-treated Smad4-positive CFPAC-1 and BxPC3 cells (Figure 7 ). Consequently, a 2 kb promoter fragment was amplified from genomic DNA and cloned into the pGL3 luciferase reporter vector. Activities of this promoter fragment in transient transfections were consistent with Smad4-dependent differences of endogenous transcript levels of LAMA3 in Smad4-positive and -negative SW480 and BxPC3 cells, respectively (Figure 8a and b) . The 2 kb promoter fragment was capable to confer TGF-b responsiveness to LAMA3 expression in BxPC3 (Figure 8b and e) and in LT97 (Figure 8c and d) cells consistent with responses of the endogenous gene in these cell lines.
As a complementary approach, we next assessed if Smad4 gene silencing in LT97 adenoma cells was adequate to suppress LAMA3 promoter activity. To that aim, we performed transient co-transfections with the LAMA3 promoter-reporter construct with either a plasmid expressing small interference RNA (siRNA) that targeted the endogenous Smad4 (Imamura et al., 2004; Jazag et al., 2005) or with the empty vector control (plasmids were kindly provided by F Kanai, Tokyo, Japan). Interestingly, both the basal promoter activity and TGF-b induction were significantly reduced by 30 and 20%, respectively (Figure 8c ). In conclusion, both cell-autonomous control circuits as well as the cellular response to exogenously added cytokine depend on Smad4.
Lastly, we asked if Smad4 binding to the SBE site at position À1.5 kb in the LAMA3 promoter was essential for Smad4 effects on LAMA3 transcription. Thus, we cloned a deletion construct devoid of the SBE site and a mutation construct with destroyed SBE site. Both of these constructs retained some responsiveness in response to TGF-b in LT97 cells (Figure 8d ) and in Smad4-re-expressing BxPC3 cells (Figure 8e ). However, when compared to the parent construct, this response was reduced to approximately half. Thus, expression of LAMA3 is regulated in part through Smad4 binding to the SBE site and in part through Smad4-dependent but SBE-independent mechanisms.
Discussion
Functional inactivation of the tumor suppressor Smad4 in colorectal and pancreatic carcinogenesis occurs upon the transition of premalignant precursor lesions to Reinacher-Schick et al., in preparation). Interestingly, direct functional proof for an association of decreased laminin-5 secretion and increased motility and invasiveness has recently been provided the group of Ziober. Using a LAMC2 knockdown strategy, they could show that suppression of LAMC2 expression followed by reduced secretion of the laminin-5 heterotrimer turned a non-invasive oral squamous carcinoma cell line to a phenotype representative of invasive tumor cells (Yuen et al., 2005) . In normal epithelia, expression of the three genes encoding laminin-5 (like that of other laminins) is tightly controlled, leading to a coordinate and balanced Smad4 regulates laminin-5 M Zapatka et al expression of the three chains followed by intracellular assembly and release of the heterotrimer in a developmental and tissue-specific manner (Simon-Assmann et al., 1998; Teller and Beaulieu, 2001) . Colorectal adenomas have consistently been found to retain normal patterns of laminin-5 in BMs, no intracellular staining was reported (Sordat et al., 1998) . This expression pattern suggests that coordinate regulation of the laminin subunits is retained in the presence of genetic alterations commonly found in premalignant stages like inactivation of APC and mutation of Ki-ras. In colorectal carcinomas, in contrast, laminin deposition in BM structures becomes discontinuous or is absent, suggesting that shut down of laminin expression is associated with genetic alterations that mediate the transition to invasive growth. Thus, our findings that the tumor and invasion suppressor Smad4 can act as a positive regulator of laminin-5 may depict a functionally relevant Smad4 target structure associated with the acquisition of invasiveness.
Besides the above-addressed absence or scarcity of BM laminin staining in colorectal carcinomas, the laminin-5-specific g2 chain is known as a marker of invasion (Pyke et al., 1994 (Pyke et al., , 1995 Sordat et al., 1998) . An intracellular accumulation of the g2 (and b3) subunit(s) is found at the invasive fronts of some colorectal cancers and in particular in budding cancer cells; however, no a3 expression can be detected at these sites (Sordat et al., 2000) . This pattern of laminin-5 g2 (and b3) expression apparently is not the direct consequence of genetic alterations, rather it is interpreted as a response of the genetically altered tumor cells to stromal signals active at the invasion fronts (Brabletz et al., 2005) . Whereas LAMC2 has been characterized as a b-catenin target gene (Hlubek et al., 2001) , activation of the Wnt/ b-catenin pathway on its own is not sufficient to perturb balanced expression of the laminin-5 heterotrimer as shown with adenoma cells in vitro and in vivo (Sordat et al., 2000) . When b-catenin is overactivated in budding tumor cells presumably through stromal growth factors, LAMC2 is induced (Sordat et al., 2000; Hlubek et al., 2001) . This pattern of regulation was also reflected in an in vitro study, where LAMC2, but not LAMA3 and LAMB3 was shown to be synergistically induced by TGF-b and hepatocyte growth factor in colorectal carcinoma cells (Olsen et al., 2003) . Selective induction of the g2 (and b3) chain, but not the a3 chain by b-cateninmediated signals is consistent with the promoter composition: an in silico promoter analysis indicated 6 and 10 T-cell factor/lymphoid enhancing factor (TCF/Lef) consensus binding sequences in the 5 kb promoter regions of the LAMB3 and LAMC2 genes, respectively. In contrast, a single TCF/Lef consensus binding site was identified 4 kb upstream of the LAMA3 transcription start site (data not shown).
Alterations in laminin-5 expression, although less intensively investigated, have also been described in pancreatic adenocarcinomas. An immunohistochemical study has revealed two types of expression patterns according to the dominant localization of the laminin-g2 chain (Takahashi et al., 2002) . The cytoplasmic expression dominant type, reminiscent of intracellular accumulation of laminin-g2 at the invasion front of colorectal carcinomas, was associated with the occurrence of postoperative hepatic metastasis and in addition was the strongest predictor for poor survival. Retention of the 'normal' BM predominant type, reflecting secretion of the heterotrimeric molecule, in contrast, was associated with tumor differentiation.
Although our insight into expression control of laminin genes is limited , it is evident that transcriptional regulation is subjected to impacts from various signalling pathways converging on the respective promoters. Tissue architecture and function are thought to be maintained by a dynamic interplay between epithelial cells and a microenvironment consisting of an extracellular matrix, diverse stromal cell types and the resulting milieu of cytokines and growth factors. Our understanding of how genetic alterations in epithelial cells impinge on this interplay has only just begun. Here we have shown that the tumor and invasion suppressor Smad4 can function as a positive transcriptional regulator of all three laminin-5 genes and thereby depict a mechanism of how loss of Smad4 may contribute to the dissolution of BM structures, one of the basic prerequisites for invasive growth. It will be interesting in the future to analyse if and how loss of Smad4 is also involved in later steps of tumor progression where expression control of the three laminin-5 chains is uncoupled leading to intracellular accumulation of the laminin-5 g2 chain in budding tumor cells in response to environmental stimuli at the invasive front of tumors.
Materials and methods

Cell culture
The human colorectal carcinoma cell lines SW480, SW620 and HT29 and human pancreatic carcinoma cell lines CFPAC-1 and BxPC3 cells were obtained from the American Type Culture Collection (Rockville, MD, USA). The human colon adenoma cell line LT97 and human keratinocyte cell line HaCaT were kindly provided by M Marian (Vienna, Austria) and N Fusenig (Heidelberg, Germany). LT97 cells were maintained in Ham's F12 medium with supplements as described (Richter et al., 2002) . All other cells were maintained in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% fetal calf serum (FCS), 2 mM glutamine, 100 U/ ml penicillin and 100 mg/ml streptomycin.
Adhesion assay
Smad4-negative and Smad4-re-expressing derivatives of the human colon carcinoma cell line SW480 have been described previously (Schwarte-Waldhoff et al., 1999; Muller et al., 2002) . Cells are routinely maintained in DMEM supplemented with antibiotics and 10% FCS (Biochrom, Berlin, Germany). To prepare matrices used in the adhesion assays, three independent Smad4-negative SW480 control clones and three Smad4-re-expressing clones, respectively, were plated on 10 cm culture dishes starting with identical cell numbers and grown until they reached a confluent state. Cells were incubated for another 5 days and then removed by treatment with 2 M urea in DMEM. The matrix retained on the culture Smad4 regulates laminin-5 M Zapatka et al dishes was washed with phosphate-buffered saline (PBS) and microscopically controlled for any residual cells. Subsequently, 2.5 Â 10 6 indicator cells derived from logarithmically growing cultures were plated onto these matrices and their adhesion and spreading was documented by phase contrast microphotography. As indicator cells, we used Smad4-re-expressing and Smad4-deficient derivatives of the SW480 cell line as well as cells from other colon cancer cell lines (SW620, HT29), all with similar results. For inhibition experiments, matrices were similarly produced in 24-well plates and preincubated with antibodies (anti-laminin-5 antibody, clone P3H9-2, raised against laminin-5 expressing human keratinocytes and characterized as adhesion-blocking antibody (Wayner et al., 1993) (Chemicon, Hampshire, UK), and anti-Flag antibody, clone M2, (Sigma, St Louis, MO, USA), used as a negative control) at the indicated concentrations in DMEM plus 2% FCS for 2 h. A total of 1 Â 10 5 indicator cells were added per well.
Preparation of matrix and conditioned medium for Western blotting Matrix used for protein preparation was produced as described above and harvested in a solubilization buffer (200 mM TrisHCl, pH 6.8; 0.1% Triton X-100; 0.1% sodium dodecyl sulfate (SDS); 5% glycerin; 1 mM phenylmethylsulfonyl fluoride and complete Protease-Inhibitor-Cocktail; Roche, Mannheim, Germany). Preparation of proteins from conditioned media was performed as described previously (Volmer et al., 2004) . In brief, cells grown to 60% confluency in standard media were incubated in serum-free medium with supplements (insulin, transferrin, selenium, hydrocortisone) for 2 days. Supernatants were harvested and cleared from floating cells and debris by steril filtration. Proteins were concentrated by ultrafiltration using Centriplus YM-3 centrifugal filter devices (Millipore, Billerica, MA, USA).
Northern and Western blotting
Northern blots and hybridizations were performed using standard procedures as described previously (SchwarteWaldhoff et al., 1999 (SchwarteWaldhoff et al., , 2000 . Chain-specific laminin-5 probes used for hybridization were prepared by reverse transcriptasepolymerase chain reaction (PCR) using specific primer pairs and RNA prepared from human HaCaT cells. For laminin-5 Western blots, samples were subjected to SDS-polyacrylamide gel electrophoresis (PAGE) on 8% polyacrylamide gels and run under standard conditions either with or without dithiothreitol. Heterotrimeric laminin-5 under non-reducing conditions and monomeric laminin-g2 were detected with monoclonal antibody MAB19562 (Chemicon) and horseradish peroxidase (HRP)-coupled anti-mouse immunoglobulin G (IgG) secondary antibody. The laminin-a3 and -b3 chains were detected with rabbit antisera H-187 and H-300 (sc-20143 and sc-20775; Santa-Cruz, Santa Cruz, CA, USA), respectively, and a secondary HRP-coupled anti-rabbit IgG antibody.
Coculture of colon carcinoma cells with fibroblastic cells and immunofluorescence Smad4-negative and Smad4-re-expressing cells were seeded on preformed confluent human skin fibroblastic cell layers as described previously (Bouziges et al., 1991 
Immunohistochemistry
Staining for laminin-g2 of normal human colon tissue and of colonic tumor xenografts was performed as described (Mizushima et al., 1998; Lu et al., 2001) . In brief, 5 mm tissue sections were deparaffinized with xylene, incubated with 0.3% hydrogen peroxide in methanol and treated with Protease XXIV (Sigma, St Louis, MO, USA) for 15 min at room temperature. The sections were then incubated with the mouse monoclonal antibody D4B5 (1:200) (Chemicon) at 41C overnight, washed with PBS and incubated for 30 min with biotinylated secondary anti-mouse antibodies (Vector Laboratories, Burlingame, CA, USA). Subsequently, the sections were incubated for 30 min with avidin-biotinyl-peroxidase complex using a Vectastain ABC kit (Vector Laboratories) and subjected to peroxidase reaction using 0.02% 3.3 0 -diaminobenzidine tetrahydrochloride as the chromogen and 0.007% hydrogen peroxide in Tris-HCl buffer, pH 7.6, for 10 min, followed by nuclear counterstaining with hematoxylin.
Chromatin immunoprecipitation
ChIP assays were performed according to a published procedure (Frank et al., 2001 ). BxPC3 and CFPAC1-1 cells were grown to confluency in 150 mm culture dishes and treated with recombinant TGF-b1 (R&D Systems, Minneapolis, MN, USA) at a concentration of 5 ng/ml for 1 h. Proteins and DNA were crosslinked by incubating the cells in 1% (v/v) formaldehyde at room temperature for 10 min and the reaction was stopped by the addition of glycine to a final concentration of 0.125 M. Cells were washed twice with Tris-buffered saline (20 mM Tris, pH 7.4, 150 mM NaCl) and lysed in SDS buffer (50 mM Tris, pH 8.1, 0.5% (v/v) SDS, 100 mM NaCl, 5 mM ethylenediaminetetraacetic acid (EDTA), protease inhibitors, Roche). Chromatin was pelleted by centrifugation and resuspended in 0.5 ml of immunoprecipitation buffer (two parts SDS buffer, one part Triton dilution buffer (100 mM Tris, pH 8.6, 100 mM NaCl, 5% (v/v) Triton X-100, 5 mM EDTA) and protease inhibitors (Roche). Chromatin was sonicated (four times for 20 s, using a Bandelin sonoplus sonicator (Bandelin electronic GmbH&Co KG, Berlin, Germany) to yield genomic DNA fragments with a bulk size of 100-500 bp. Immunoprecipitaton was performed overnight at 41C with polyclonal antibodies specific for either Smad4 (3 mg H-552, Santa Cruz) or a-actin (3 mg BM, Santa Cruz) as an unspecific control. Immune complexes were recovered by adding 30 ml of blocked protein G beads and incubated for 2 h at 41C. The beads were washed successively in 1 ml of mixed micelle buffer (20 mM Tris, pH 8.1, 150 mM NaCl, 5 mM EDTA, 5% (w/v) sucrose, 1% Triton X-100 and 0.2% (v/v) SDS), buffer 500 (50 mM N-2-hydroxyethylpiperazine-N 0 -2-ethanesulfonic acid, pH 7.5, 0.1% (w/v) deoxycholic acid, 1% Triton X-100, 500 mM NaCl and 1 mM EDTA), LiCl Detergent Wash Buffer (10 mM Tris, pH 8.0, 0.5% deoxycholic acid, 0.5% NP-40, 250 mM LiCl and 1 mM EDTA) and Tris-EDTA (TE) (10 mM Tris, pH 7.5, 1mM EDTA). Washed precipitates were incubated overnight at 651C in elution buffer (TE, 1% SDS, 0.1 M NaHCO 3 ) to reverse the formaldehyde crosslinking. DNA fragments were purified with a QiaQuick Spin Kit (Qiagen, Hilden, Germany) according to the manufacturer's recommendations. The À1.5 kb region of the LAMA3 promoter was amplified using 2 ml of the extracted DNA per reaction and primers 5 0 -GCCTCTGACACAG GAAGTGG-3 0 and 5 0 -AGCCCTGCAGAAACTTG-AAC-3 0 in 32 cycles of amplification to yield a fragment of 213 bp.
Vector construction and transient transfection A 2 kb promoter fragment (LAMA3-2 kb) upstream of exon1 of the human laminin-a3A gene was amplified by genomic PCR with primers 5 0 -AGTAGATCTGCAGGAACCTCTG CCTC-TTC-3 0 and 5 0 -GATGCTAGCCGTTTGTGCAAGA AAAGATTG-3 0 and cloned into the pGL3-basic vector (Promega, Mannheim, Germany). A unique StuI restriction site is located directly downstream of the SBE site at position À1516. An SBE-deficient deletion construct was generated by double-digestion of the LAMA3-2 kb construct with NheI (within the MCS of pGL3 basic) and StuI. A point mutation was introduced into the SBE site in the LAMA3-2 kb construct using the Quick-Change Site directed mutagenesis kit (Stratagene, La Jolla, CA, USA) with the primer oligonucleotides 5 0 -GCTGATGACAGTGCTGTCAACACTGGC AGATGTGCG-3 0 and 5 0 -CGCACATCTG-CAGTTTGACA GCACTGTCATCAGC-3 0 . All constructs were sequence-verified. The Smad4 knockdown plasmid vector pcPUR þ U6-Smad4i and the respective empty vector cassette were kindly provided by F Kanai (Imamura et al., 2004; Jazag et al., 2005) . DNA used for transient transfections was prepared with a Plasmid Midi Kit (Qiagen, endotoxin-free).
For transient transfections, cells were grown to a confluency of approximately 50% in 24-well plates and transfected with 400 ng of the respective promoter construct (pGL3-basic, Promega) and 10 ng internal control (phRL-SV40, Promega) using Effectene (Qiagen) in accordance with the manufacturer's recommendations. TGF-b was added 5 h after transfection at a final concentration of 10 ng/ml when indicated. The cells were harvested after 24 h and the luciferase assays were carried out as triplicates using a luminometer (Berthold LB 9501) and the Dual-Luciferase-Reporter Assay System (Promega).
